Equities
  • Price (EUR)34.68
  • Today's Change-0.93 / -2.61%
  • Shares traded15.00
  • 1 Year change-41.18%
  • Beta1.1811
Data delayed at least 15 minutes, as of Jul 01 2025 07:08 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Bruker Corporation is a developer, manufacturer and distributor of high-performance scientific instruments and analytical and diagnostic. Its segments include Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies (BEST). BSI segment designs, manufactures and distributes life science tools based on magnetic resonance technology and offers automated laboratory research. BSI CALID segment designs, manufactures and distributes life science mass spectrometry, applied spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. BSI NANO designs, manufactures and distributes advanced x-ray instruments, atomic force microscopy instrumentation, and fluorescence optical microscopy instruments. BEST segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and energy physics research.

  • Revenue in USD (TTM)3.45bn
  • Net income in USD79.60m
  • Incorporated2000
  • Employees11.40k
  • Location
    Bruker Corp40 MANNING RDBILLERICA 01821United StatesUSA
  • Phone+1 (978) 663-3660
  • Fax+1 (978) 663-5585
  • Websitehttps://www.bruker.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
BRKR:NSQ since
announced
Transaction
value
Recipe Chemicals Instruments GmbhDeal completed16 Apr 202516 Apr 2025Deal completed9.03%--
Dynamic Biosensors GmbHDeal completed02 Oct 202402 Oct 2024Deal completed-37.24%--
Data delayed at least 15 minutes, as of Jul 01 2025 21:00 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.